The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sintilimab (anti-PD-1 antibody) combined with chidamide (an oral subtype-selective HDACi) followed by P-GemOx regimen in patients with treatment-naïve extranodal natural killer/T cell lymphoma (TN-ENKTL): A multicenter, open-label, single-arm, phase II study (SCENT-2 trial).
 
Huiqiang Huang
No Relationships to Disclose
 
Yan Gao
No Relationships to Disclose
 
Xueping Li
No Relationships to Disclose
 
Xuanye Zhang
No Relationships to Disclose
 
Xiaoxiao Wang
No Relationships to Disclose
 
Bing Bai
No Relationships to Disclose
 
Ru Feng
No Relationships to Disclose
 
Mingwei Fu
No Relationships to Disclose